Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted GraftsYan Beauverd, Yves Chalandon, Carmen De Ramón Ortiz et al.|Transplantation and Cellular Therapy|2020Cited by 1
The AML EBMT Cytogenetic Risk Score for Acute Myeloid Leukaemia (AML) Is Prognostic for Outcomes of Allogeneic Stem Cell (HSCT)Yan Beauverd, Yves Chalandon, Sarah Morin et al.|Blood|2020Cited by 0